Antifungal Drugs: Technologies and Global Markets

Report Code: PHM029H

Publish Date: Dec 2021

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for antifungal drugs should grow from $14.5 billion in 2021 to $17.9 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.

Report Includes

  • 107 data tables and 30 additional tables
  • An updated review of the current and future potential for the global markets for antifungal drugs
  • Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of key market dynamics (DROs) for antifungal drugs, regulatory scenario, and COVID-19 impact on the progress of this market
  • Comparative study of the two primary segments of antifungal medications – prescription antifungal drugs and over the counter (OTC) antifungal drugs – and issues facing the use of these products
  • Review of antifungal agents and their classification based on the mechanism of action, approved therapeutic products and relevant patents with their expiration dates
  • Information pertaining to R&D efforts, breakthrough therapy innovations, clinical trials of novel drug developments, their technologies and intended clinical applications
  • Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
  • Descriptive company profiles of the major market players, including Dr. Reddy’s Laboratories, Merck & Co., Inc., Sanofi S.A., Pfizer Inc., Bayer AG and Perrigo Company PLC

Report Scope

The aim of this report is to initially conduct a review of the antifungal drugs currently available; explore the issues facing the use of antifungal drugs; and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications. The key objective is also to conduct and provide an analysis of the market value, growth rates, market shares and market development, and examine the market dynamics and market factors influencing the growth and development of this market.

This report also looks at the challenges and potential threats facing the industry and the factors influencing the market shares of the major market suppliers as well as smaller manufacturers in local markets. The emphasis of this report is to provide the reader with:

  • A detailed analysis of the revenues and forecasts for the global antifungal drug market with a more-detailed analysis and forecast of the revenues for the global market sub-divided by major market sub-segments by geographic region and selected country.
  • A detailed analysis of the global market shares together with a more detailed analysis of the market share by geographic regions and selected country.

In addition, this analysis provides:

  • A detailed review of the current products, their indications and availability for all of the market segments identified.
  • Profiles of the individual market sub-segments within the major market segments analyzed and the distinguishing features of each of the market sub-segments.
  • A review of the major market opportunities through the recognition of specific high-growth and emerging market opportunities
  • Brief descriptions of the historical development for each of the major market segments.
  • Profiles of the leading suppliers of antifungal drugs, together with related information about specific products.

The study will allow the reader to:

  • Evaluate the effect of strategic factors, such as technology-driven change and industry consolidation, for the antifungal drug market.
  • Investigate the current market dynamics that are driving change in the antifungal drug market.
  • Assess future growth opportunities in the antifungal drug market.
  • Review the main products in each sector and plan a product-entry strategy in line with the strengths and weaknesses of the competition.Realize an individual company’s position in the market and gain insight into the future of the market and the opportunities that exist.

The analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. Company-specific information, including sales figures, product pipeline status, and R&D trends, is provided throughout the report.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Antifungal Drugs: Technologies and Global Markets295Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market Dynamics6Free
Chapter- 4: Introduction to Fungi and the Antifungal Drug Market34Free
Chapter- 5: Common Environmental Fungi15Free
Chapter- 6: Review of Antifungal Agents24Free
Chapter- 7: New and Innovative Antifungals: Current Developments, Clinical Trials and Product Pipelines21Free
Chapter- 8: Global Market for Antifungal Medications9Free
Chapter- 9: North American Market for Antifungal Drugs16Free
Chapter- 10: European Market for Antifungal Drugs28Free
Chapter- 11: Asia-Pacific Market for Antifungal Drugs34Free
Chapter- 12: Latin American Market for Antifungal Drugs25Free
Chapter- 13: Middle Eastern/African Market for Antifungal Drugs18Free
Chapter- 14: Competitive Lanscape3Free
Chapter- 15: Company Profiles24Free
Chapter- 16: Appendix A4Free
Chapter- 17: Appendix B13Free
Chapter- 18: Appendix C4Free
Chapter- 19: Appendix D3Free
Chapter- 20: Appendix E3Free
Published - Jun-2020| Analyst - Paul Taylor| Code - PHM029G

Report Highlights

The global market for antifungal drugs should grow from $14.6 billion in 2019 to reach $17.6 billion by 2024, at a compound annual growth rate (CAGR) of 3.8% for the forecast period of 2019-2024.

Report Includes

  • 116 data tables and 27 additional tables
  • An overview of the global markets for antifungal drugs within the pharmaceuticals industry
  • Analyses of the global market trends, with data corresponding to market size from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Comparative study of the two primary segments of antifungal medications – over-the-counter (OTC) and prescription based – and issues facing the use of these products
  • Briefing about therapeutics in early development such as new molecular and biological entities from traditional pharmaceutical sources, naturally derived synthetic chemicals, and biological sources
  • Review of antifungal agents and their classification based on the mechanism of action, approved therapeutic products and relevant patents with their expiration dates
  • Information pertaining to R&D efforts, breakthrough therapy innovations, clinical trials of novel drug developments, their technologies and intended clinical applications
  • Market share analysis of leading suppliers of antifungal drugs with related information about specific products, and their key competitive landscape
  • Descriptive company profiles of major market players, including Astellas Pharma Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., Gilead Sciences Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Pfizer Inc., Sanofi S.A., and Merck & Co., Inc.
Published - Mar-2017| Analyst - Paul Taylor| Code - PHM029F

Report Highlights

The global market for antifungal drugs was valued at $13.1 billion in 2016. The market should reach $16.1 billion by 2021, growing at a compound annual growth rate (CAGR) of 4.2% from 2016 to 2021.

Report Includes

  • An overview of the global market for antifungal drugs.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Identification of new antifungal research, development, and drug applications.
  • Heavy focus on therapeutics in early development such as new molecular and biological entities from traditional pharmaceutical sources, naturally derived synthetic chemicals, and biological sources.
  • Information on over the counter (OTC) vs. prescription products.
  • Profiles of major players in the industry.
Published - Jun-2014| Analyst - Mary Anne Crandall| Code - PHM029E

Report Highlights

The global market for human antifungal therapeutics reached nearly $11.6 billion in 2012 and $11.8 billion in 2013. This market is expected to grow to nearly $13.9 billion in 2018 with a compound annual growth rate (CAGR) of 3.2% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the global market for human antifungal therapeutics
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Identification of new antifungal research, development, and drug applications
  • Information on over the counter (OTC) vs. prescription products
  • Comprehensive profiles of leading companies in the industry.

Published - Jul-2012| Analyst - Mary Anne Crandall| Code - PHM029D

Report Highlights

The global market for antifungal therapeutics was valued at $10.7 billion in 2011 and is projected to reach $12.2 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.7%.

Published - Apr-2010| Analyst - Michael Delander| Code - PHM029C

Report Highlights

  • The global market for human antifungal therapeutics was valued at $9.8 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of approximately 3.8% to reach $11.3 billion in 2014.
  • The Latin and South American region will experience the greatest compound annual growth rate (CAGR) of 8.3%, reflecting an increase in revenues from $637 million in 2009 to $949 million in 2014.
  • In North America, human antifungal therapeutics were valued at $3.9 billion in 2009 and are expected to increase at a 0.7% compound annual growth rate (CAGR) to reach $4 billion in 2014.
Published - Mar-2007| Analyst - Danielle West| Code - PHM029B

Report Highlights

  • The total global market for antifungal agents was worth more than $13.5 billion in 2005 and declined to just under $12.2 billion in 2006. The market will continue to dip through 2007 to $11.9 billion but will recover to more than $14.7 billion, a compound annual growth rate (CAGR) of 2.8%
  • Antifungal agents for humans held the highest share of the market through the forecast period. In 2007 they will be worth more than $11.2 billion and will reach nearly $14 billion by 2012, a CAGR of 4.5%.
  • Trends for fungal infections among animals are still a major concern as industry trends indicate. The market for animal antifungals will be worth $107 million in 2007 and will reach $110.7 million by 2012, a CAGR of 3.5%.
Published - Apr-2003| Analyst - Lynn Gray| Code - PHM029A

Report Highlights

  • The market for antifungal drugs is estimated at $5.9 billion in 2002, including both prescription and OTC products.
  • Overall, the market is projected to rise at an average annual growth rate (AAGR) of 7.9% through 2007 to $8.7 billion.
  • There are about 30 branded prescription systemic and topical antifungal agents on the market and several dozen over-the-counter branded and generic topical antifungal products.
  • Products from several entirely new categories of compounds will be introduced during the forecast period.
  • More than a dozen new prescription products are in clinical development and will contribute to the growth in this market.

Related Reports

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

Published - Jul 2023 | Publisher - BCC Publishing | Code - BIO113D

The global nanoparticles in biotechnology, drug development, and drug delivery systems market should reach $156.8 billion by 2028 from $102.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.8% for the forecast period of 2023 to 2028.

Antibiotics: Technologies and Global Markets

Published - Jun 2023 | Publisher - BCC Publishing | Code - PHM025F

The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.

Global Markets for Infectious Disease Treatments

Published - Jan 2022 | Publisher - BCC Publishing | Code - PHM061E

The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Antifungal Drugs: Technologies and Global Markets
Customize Report